|
RGS1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.51398943066306E-13 |
| Normal-vs-Stage2 |
3.844400E-04 |
| Normal-vs-Stage3 |
1.104430E-03 |
| Normal-vs-Stage4 |
1.333650E-02 |
| Stage1-vs-Stage2 |
1.374630E-01 |
| Stage1-vs-Stage3 |
4.332200E-01 |
| Stage1-vs-Stage4 |
3.707400E-01 |
| Stage2-vs-Stage3 |
5.950500E-02 |
| Stage2-vs-Stage4 |
8.236300E-02 |
| Stage3-vs-Stage4 |
9.461400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
1.7297052679055E-11 |
| Normal-vs-Asian |
9.258000E-02 |
| Caucasian-vs-AfricanAmerican |
4.280600E-01 |
| Caucasian-vs-Asian |
1.433600E-02 |
| AfricanAmerican-vs-Asian |
1.498960E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.6242562850266E-12 |
| Normal-vs-Female |
7.65942864688895E-12 |
| Male-vs-Female |
1.364250E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.9544000000058E-06 |
| Normal-vs-Extreme_Weight |
1.62950000159867E-08 |
| Normal-vs-Obese |
5.70300000002355E-07 |
| Normal-vs-Extreme_Obese |
1.472010E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.532370E-01 |
| Normal_Weight-vs-Obese |
1.371800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.349200E-01 |
| Extreme_Weight-vs-Obese |
8.431400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.246400E-02 |
| Obese-vs-Extreme_Obese |
7.391600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.239800E-03 |
| Normal-vs-Age(41-60Yrs) |
2.38649999761975E-09 |
| Normal-vs-Age(61-80Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(81-100Yrs) |
1.658160E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.581200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.315000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.304200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.763400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.742000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.613000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
2.22089999999397E-05 |
| Normal-VS-KIRP CIMP |
7.181500E-03 |
| Normal-VS-Unclassified PRCC |
1.965630E-04 |
| Type1 PRCC-VS-Type2 PRCC |
7.036800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.340400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.450600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.137700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.037600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.430100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.4614999966951E-08 |
| Normal-vs-N1 |
4.204300E-03 |
| Normal-vs-N2 |
1.883520E-02 |
| N0-vs-N1 |
4.799200E-01 |
| N0-vs-N2 |
6.165400E-01 |
| N1-vs-N2 |
4.383000E-01 |
|
|
